What daily dose of venlafaxine best approximates the serum concentration achieved by a patient who has been self‑tapering 150 mg every other day for four weeks, in order to begin a hyperbolic taper?

Approximate Daily Dose for Hyperbolic Taper

A patient taking 150 mg venlafaxine every other day for 4 weeks has achieved an approximate steady-state serum concentration equivalent to roughly 75 mg daily, which should serve as the starting point for a hyperbolic taper.

Pharmacokinetic Rationale

When taking 150 mg every other day, the patient is effectively receiving 75 mg per day on average. However, the actual serum concentration pattern is more complex due to venlafaxine's elimination half-life:

• Venlafaxine elimination half-life: approximately 5 hours 1
• O-desmethylvenlafaxine (ODV, active metabolite) half-life: approximately 11 hours 1

After 4 weeks of every-other-day dosing, the patient has reached a quasi-steady state where:

• Drug levels peak on dosing days
• Levels decline substantially (but not completely) on off days
• The active metabolite ODV provides some continuity due to its longer half-life

Serum Concentration Approximation

The time-averaged serum concentration from 150 mg every other day approximates 60-75 mg daily when accounting for:

1. Incomplete washout between doses: With a ~11-hour half-life for ODV, approximately 25-30% of the metabolite remains after 48 hours
2. Accumulation of active metabolite: ODV contributes significantly to therapeutic effect and accumulates more than the parent compound
3. Individual variability: Dose-corrected concentrations show high interindividual variability (CV 166% for venlafaxine, 60% for ODV) 2

Recommended Starting Dose for Hyperbolic Taper

Begin the hyperbolic taper at 75 mg daily (either immediate-release divided doses or extended-release once daily).

Clinical Considerations:

• Verify tolerance: Observe for 3-7 days at 75 mg daily to ensure the patient tolerates this stabilization without withdrawal symptoms
• If withdrawal emerges: The patient may need 100 mg daily initially, as their actual steady-state concentration may have been higher than calculated
• Age considerations: If the patient is >65 years, dose-corrected concentrations are 42% higher 3, suggesting they may need only 50-60 mg daily to match their previous exposure

Hyperbolic Taper Strategy

Once stabilized on the equivalent daily dose:

• Reduce by 10% of the current dose every 2-4 weeks 4
• Slower reductions as dose decreases: The hyperbolic approach means absolute dose reductions become smaller over time (e.g., 75→67.5→60.7→54.6 mg)
• Monitor withdrawal symptoms: Adjust taper speed based on tolerability, not a fixed schedule
• Address protracted withdrawal: Expect potential dysphoria, insomnia, or irritability months after discontinuation 4

Common Pitfalls to Avoid

1. Assuming simple averaging: Don't assume every-other-day dosing equals exactly half the daily dose in terms of serum exposure
2. Ignoring the active metabolite: ODV contributes substantially to both efficacy and withdrawal risk
3. Rushing stabilization: Allow adequate time (at least 1 week) at the daily equivalent dose before beginning the taper
4. Fixed taper schedules: Withdrawal symptoms should guide taper speed, not arbitrary timelines 5

The patient's self-taper has already reduced exposure significantly, but the every-other-day pattern creates fluctuating levels that increase withdrawal risk. Stabilizing on a consistent daily dose before implementing a gradual hyperbolic taper will minimize discontinuation symptoms while safely reducing the medication.